Cite
HARVARD Citation
Cohen, H. et al. (2015). Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Lupus. pp. 1087-1094. [Online].